Coronavirus Disease 2019 Causing Infection of Transplanted Lung Allograft : A Pitfall of Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus-2 Pretransplant
© 2023 The Authors..
Coronavirus disease 2019 (COVID-19) pandemic has led to considerable morbidity and mortality across the world. Lung transplant is a viable option for a few with COVID-19-related lung disease. Whom and when to transplant has been the major question impacting the transplant community given the novelty of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe a pitfall of presumed prolonged shedding of SARS-CoV-2 in a patient with COVID-19 associated acute respiratory distress syndrome leading to COVID-19 pneumonia after lung transplant. This raises concerns that replication-competent SARS-CoV-2 virus can persist for months post-infection and can lead to re-infection of grafts in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Mayo Clinic proceedings. Innovations, quality & outcomes - 7(2023), 2 vom: 01. Apr., Seite 93-98 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shah, Sadia Z [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 23.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.mayocpiqo.2023.01.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351554866 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351554866 | ||
| 003 | DE-627 | ||
| 005 | 20231226051643.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mayocpiqo.2023.01.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1171.xml |
| 035 | |a (DE-627)NLM351554866 | ||
| 035 | |a (NLM)36644594 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shah, Sadia Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus Disease 2019 Causing Infection of Transplanted Lung Allograft |b A Pitfall of Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus-2 Pretransplant |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) pandemic has led to considerable morbidity and mortality across the world. Lung transplant is a viable option for a few with COVID-19-related lung disease. Whom and when to transplant has been the major question impacting the transplant community given the novelty of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe a pitfall of presumed prolonged shedding of SARS-CoV-2 in a patient with COVID-19 associated acute respiratory distress syndrome leading to COVID-19 pneumonia after lung transplant. This raises concerns that replication-competent SARS-CoV-2 virus can persist for months post-infection and can lead to re-infection of grafts in the future | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a BAL, bronchoalveolar lavage | |
| 650 | 4 | |a BSL-3, Biosafety level-3 | |
| 650 | 4 | |a COVID-19, coronavirus disease 2019 | |
| 650 | 4 | |a CP, convalescent plasma | |
| 650 | 4 | |a CT, computed tomography | |
| 650 | 4 | |a LT, lung transplant | |
| 650 | 4 | |a NPS, nasopharyngeal swab | |
| 650 | 4 | |a RT-PCR, reverse transcriptase–polymerase chain reaction | |
| 650 | 4 | |a SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 | |
| 650 | 4 | |a VV-ECMO, veno-venous extracorporeal membrane oxygenation | |
| 700 | 1 | |a Alvarez, Francisco G |e verfasserin |4 aut | |
| 700 | 1 | |a Sanghavi, Devang K |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno Franco, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a Isha, Shahin |e verfasserin |4 aut | |
| 700 | 1 | |a Marquez, Christopher P |e verfasserin |4 aut | |
| 700 | 1 | |a Libertin, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Guru, Pramod K |e verfasserin |4 aut | |
| 700 | 1 | |a Sareyyupoglu, Basar |e verfasserin |4 aut | |
| 700 | 1 | |a Pham, Si M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mayo Clinic proceedings. Innovations, quality & outcomes |d 2017 |g 7(2023), 2 vom: 01. Apr., Seite 93-98 |w (DE-627)NLM286756471 |x 2542-4548 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:2 |g day:01 |g month:04 |g pages:93-98 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mayocpiqo.2023.01.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 2 |b 01 |c 04 |h 93-98 | ||